Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: China

Fortune SGAM Pharmaceutical and Bios Selection Fund

+ Add to Watchlist

FSPHBIS:CH

1.33 CNY 0.01 0.75%

As of 10:52:12 ET on 01/30/2015.

Snapshot for Fortune SGAM Pharmaceutical and Bios Selection Fund (FSPHBIS)

Year To Date: +9.40% 3-Month: -0.89% 3-Year: - 52-Week Range: 1.12 - 1.39
1-Month: +9.40% 1-Year: +5.68% 5-Year: - Beta vs : -

Mutual Fund Chart for FSPHBIS

No chart data available.
  • FSPHBIS:CH 1.33
  • 1M
  • 1Y
Interactive FSPHBIS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FSPHBIS

Fortune SGAM Pharmaceutical and Bios Selection Fund is an open-ended fund incorporated in China. The Fund seeks to achieve long-term stable return via controlling risk and liquidity. The Fund invests at least 80% of its total equity investments into pharmaceutical and bios companies listed in China.

Inception Date: 03-02-2012 Telephone: 86-21-38505888 Tel
Managers: FAN HONG-BING / WANG ZHI-WEI
Web Site: www.fsfund.com

Fundamentals for FSPHBIS

NAV (on 2015-01-30) 1.33
Assets (M) (on 2014-12-31) 780.63
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 1,000.00

Dividends for FSPHBIS

No dividends reported

Fees & Expenses for FSPHBIS

Front Load 1.50
Back Load 1.50
Current Mgmt Fee 1.50
Redemption Fee 1.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FSPHBIS

Filing Date: 09/30/2014
Name Position Value % of Total
Xiangxue Pharmaceutical Co Ltd 4,820,045 109,366,821 0.000%
China National Medicines Corp 1,608,480 43,348,536 0.000%
Zhejiang Hisun Pharmaceutical 2,343,501 40,261,347 0.000%
Sinocare Inc 965,302 40,137,257 0.000%
Guizhou Yibai Pharmaceutical C 1,011,348 37,925,550 0.000%
China National Accord Medicine 717,503 37,094,905 0.000%
Tianjin Chase Sun Pharmaceutic 1,154,976 33,875,446 0.000%
Shanghai Kehua Bio-Engineering 1,217,519 32,799,962 0.000%
Zhejiang NHU Co Ltd 1,999,440 30,151,555 0.000%
SDBC 4.55 10/24/14 30,000 30,015,000 0.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil